Bidirectional transcription at the PPP2R2B gene locus in spinocerebellar ataxia type 12.
Bidirectional transcription at the PPP2R2B gene locus in spinocerebellar ataxia type 12.
复制标题
12 型脊髓小脑共济失调中 PPP2R2B 基因位点的双向转录。
DOI:
10.1101/2023.04.02.535298
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Li,PanP
中科院分区:
文献类型:
--
作者:
Zhou,Chengqian;Liu,HansB;Bakhsh,FatemehJ;Wu,Bin;Ying,Mingyao;Margolis,RussellL;Li,PanP
BackgroundSpinocerebellar ataxia type 12 (SCA12) is a neurodegenerative disease caused by expansion of a CAG repeat in thePPP2R2Bgene.ObjectiveIn this study, we tested the hypothesis that thePPP2R2B antisense(PPP2R2B‐AS1) transcript containing a CUG repeat is expressed and contributes to SCA12 pathogenesis.MethodsExpression ofPPP2R2B‐AS1transcript was detected in SCA12 human induced pluripotent stem cells (iPSCs), iPSC‐derived NGN2 neurons, and SCA12 knock‐in mouse brains using strand‐specific reverse transcription polymerase chain reaction. The tendency of expandedPPP2R2B‐AS1(expPPP2R2B‐AS1) RNA to form foci, a marker of toxic processes involving mutant RNAs, was examined in SCA12 cell models by fluorescence in situ hybridization. The apoptotic effect ofexpPPP2R2B‐AS1transcripts on SK‐N‐MC neuroblastoma cells was evaluated by caspase 3/7 activity. Western blot was used to examine the expression of repeat associated non‐ATG‐initiated translation ofexpPPP2R2B‐AS1transcript in SK‐N‐MC cells.ResultsThe repeat region in thePPP2R2Bgene locus is bidirectionally transcribed in SCA12 iPSCs, iPSC‐derived NGN2 neurons, and SCA12 mouse brains. TransfectedexpPPP2R2B‐AS1transcripts induce apoptosis in SK‐N‐MC cells, and the apoptotic effect may be mediated, at least in part, by the RNA secondary structure. TheexpPPP2R2B‐AS1transcripts form CUG RNA foci in SK‐N‐MC cells.expPPP2R2B‐AS1transcript is translated in the alanine open reading frame (ORF) via repeat‐associated non‐ATG translation, which is diminished by single‐nucleotide interruptions within the CUG repeat and MBNL1 overexpression.ConclusionsThese findings suggest thatPPP2R2B‐AS1contributes to SCA12 pathogenesis and may therefore provide a novel therapeutic target for the disease. © 2023 International Parkinson and Movement Disorder Society.